Skip to content
Aperlena
Language:

Germany - Medicines - Open House Biosimilars discount agreements 2026-25 - Follitropin alfa

Original Deutschland - Arzneimittel - Open House Biologika Rabattverträge 2026-25 - Follitropin alfa

Open Contract notice 673 days left
Watch this tender

Deadline 31 Jul. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 17 Jul, questions by 17 Jul, draft by 24 Jul. Log in

  1. Published
  2. Today
  3. Deadline open for 784 days
  4. Awarded pending

Summary

Machine-generated summary

Techniker Krankenkasse (TK), a German statutory health insurer, intends to conclude rebate agreements under Section 130a paragraph 8 SGB V with all suitable pharmaceutical entrepreneurs for the active substance Follitropin alfa. The procedure is an open house process with several lots as described in the lot information. No individual negotiations take place and uniform conditions apply. No exclusivity is granted to any contracting party. The contract runs for a maximum of 24 months starting 01.08.2026 and ends at the latest on 31.07.2028 regardless of the date of signature. Further details are in the participation and contract documents.

Description

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa (es werden mehrere Lose gebildet, siehe Angaben bei den jeweiligen Losen) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.08.2026. Der Vertrag endet spätestens am 31.07.2028, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen. Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Follitropin alfa zu schließen.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

52 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now July 31, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,074,256
9,826 open across Europe right now
Buyer track record on Aperlena
55 notices tracked · 0 awarded

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

673 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close